Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ (146,594)	$ 8,595	$ 104,778
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	69,810	70,923	72,506
Non-cash lease expense	26,600	33,321	44,518
Stock-based compensation	14,823	15,646	12,367
Inventory write-down	48,221	88,108	43,286
Foreign currency losses	1,709	1,039	8,245
(Gain) loss on disposal of assets	(84)	780	33
Impairment of fixed assets, goodwill and other intangibles	181,069	0	9,916
Deferred taxes	(55,477)	(18,090)	(51,626)
Changes in operating assets and liabilities:
Accounts receivable, net	(7,763)	(22,679)	(11,449)
Inventories, net	30,318	(13,222)	(2,972)
Prepaid expenses and other	579	6,359	2,758
Other assets	(1,054)	45	3,099
Accounts payable	(7,294)	(10,083)	9,263
Accrued expenses	(27,582)	(37,701)	(120,833)
Other liabilities	(15,539)	(4,402)	(15,827)
Net cash provided by operating activities	111,742	118,639	108,062
Cash flows from investing activities:
Purchases of property and equipment	(41,583)	(58,490)	(59,056)
Proceeds on investment sales	18,378	18,147	5,932
Purchases of investments	(14,757)	(16,883)	(13,955)
Acquisitions (net of cash acquired)	0	(77,275)	0
Net cash used in investing activities	(37,962)	(134,501)	(67,079)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards	(2,063)	4,561	27,052
Payment of cash dividends	(11,927)	(77,622)	(77,015)
Repurchase of shares of common stock	0	(13,011)	(70,045)
Finance lease principal payments	(2,886)	(3,198)	(1,919)
Contingent consideration payments	(6,300)	0	0
Payment of debt issuance cost	0	0	(5,077)
Payments on debt	(125,000)	(10,000)	(432,500)
Proceeds from debt	15,000	110,000	460,000
Net cash (used in) provided by financing activities	(133,176)	10,730	(99,504)
Effect of exchange rate changes on cash	(9,778)	(3,536)	(16,347)
Net decrease in cash and cash equivalents	(69,174)	(8,668)	(74,868)
Cash and cash equivalents, beginning of period	256,057	264,725	339,593
Cash and cash equivalents, end of period	$ 186,883	$ 256,057	$ 264,725